Feb 25 (Reuters) - Boehringer Ingelheim has prevailed in the trial of ... key ingredient ranitidine could degrade into NDMA, a carcinogen, over time or when exposed to heat. GSK, which faced ...

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

Pharmaceutical giant GSK has won a potentially expensive personal injury case in the US over its heartburn medicine Zantac. Angela Valadez, an 89-year-old woman living in the state of Illinois ...

Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...

Twelve days after GSK secured a key win in Florida ... to take to early trials. On the first track, plaintiffs have retained 10 experts to offer their opinions on whether ranitidine can cause ...